TCMD, US87874P1012

Tactile Medical stock holds at USD 20.00 with results ahead

Published on 09/22/2026 at 15:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Tactile Medical stock is priced at USD 20.00 on September 22, 2026. Its Q2 revenue reached USD 82.5 million, up 11 percent year over year.

TCMD, US87874P1012, Illustration mit AI erstellt.
TCMD, US87874P1012, Illustration mit AI erstellt.

Tactile Medical stock (ISIN US87874P1012) is priced at USD 20.00 on Nasdaq as of September 22, 2026, giving investors a dated market reference alongside the company's latest operating figures. The company reported second-quarter revenue of USD 82.5 million in Q2 2026, an 11 percent increase from the prior-year quarter.

Revenue reaches USD 82.5 million

The Q2 2026 revenue result provides the clearest operating measure for Tactile Medical. Revenue of USD 82.5 million was 11 percent higher than in Q2 2025, showing measurable year-over-year expansion in the period reported by the company.

The comparison matters because it links the stock's September 22, 2026 market level to a current reporting period rather than to an older annual figure. The 11 percent increase is the article's key quantified operating comparison.

Market value frames the stock

At USD 20.00 on Nasdaq on September 22, 2026, Tactile Medical's share price supplies the current market figure for the stock. The price and the Q2 2026 revenue figure place valuation discussion around a company generating USD 82.5 million in quarterly sales, while avoiding conclusions that are not supported by a dated earnings or cash flow measure.

For investors, the next useful checkpoint is the company's following reported period. Revenue growth of 11 percent in Q2 2026 is concrete, but the stock's further direction will depend on whether later figures confirm that pace and show how sales translate into earnings and cash generation.

Stock reference for September 22

Tactile Medical stock stands at USD 20.00 on Nasdaq as of September 22, 2026. The dated price and the Q2 2026 revenue of USD 82.5 million, up 11 percent year over year, are the central reference points for the current company picture.

Tactile Medical stock facts

  • Company: Tactile Medical, Inc.
  • ISIN: US87874P1012
  • Ticker: TCMD
  • Trading venue: Nasdaq
  • Price as of September 22, 2026: USD 20.00
  • Sector / Industry: Health Care / Health Care Equipment

More news and analyses on Tactile Medical stock

Disclaimer...

en | US87874P1012 | TCMD | boerse | 70156039 | bgmi